CNGLX
Price
$21.39
Change
-$0.15 (-0.70%)
Updated
Sep 20 closing price
RWIBX
Price
$66.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

CNGLX vs RWIBX

Header iconCNGLX vs RWIBX Comparison
Open Charts CNGLX vs RWIBXBanner chart's image
Commonwealth Global
Price$21.39
Change-$0.15 (-0.70%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$66.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CNGLX vs RWIBX Comparison Chart
Loading...
VS
CNGLX vs. RWIBX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNGLX is a StrongBuy and RWIBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 128B vs. CNGLX (17.6M). RWIBX pays higher dividends than CNGLX: RWIBX (1.05) vs CNGLX (0.00). CNGLX was incepted earlier than RWIBX: CNGLX (22 years) vs RWIBX (22 years). RWIBX is a more actively managed with annual turnover of: 27.00 vs. CNGLX (9.00). CNGLX has a lower initial minimum investment than RWIBX: CNGLX (200) vs RWIBX (250). RWIBX annual gain was more profitable for investors over the last year : 23.75 vs. CNGLX (20.24). RWIBX return over 5 years is better than : 42.68 vs. CNGLX (38.27).
CNGLXRWIBXCNGLX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years22 years-
Gain YTD9.86113.56273%
Front LoadN/AN/A-
Min. Initial Investment20025080%
Min. Initial Investment IRAN/AN/A-
Net Assets17.6M128B0%
Annual Yield % from dividends0.001.05-
Returns for 1 year20.2423.7585%
Returns for 3 years3.387.3746%
Returns for 5 years38.2742.6890%
Returns for 10 years27.0949.0455%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.940.75
+17.90%
Genfit SA
NNI112.94-2.01
-1.75%
Nelnet
ILMN131.14-3.25
-2.42%
Illumina
SPRB0.44-0.01
-2.59%
Spruce Biosciences
APLT7.70-0.30
-3.75%
Applied Therapeutics